Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, Takefumi Suzuki, Masaru Mimura, Hiroyoshi Takeuchi

研究成果: Comment/debate査読

抄録

In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.

本文言語English
ページ(範囲)902
ページ数1
ジャーナルNeuropsychopharmacology
45
5
DOI
出版ステータスPublished - 2020 4 1

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

フィンガープリント 「Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル